Effect of p27 Deficiency and Rapamycin on Intimal Hyperplasia: In Vivo and In Vitro Studies Using a p27 Knockout Mouse Model
- 1 June 2001
- journal article
- Published by Elsevier in Laboratory Investigation
- Vol. 81 (6), 895-903
- https://doi.org/10.1038/labinvest.3780298
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Downregulation of cyclin-dependent kinase 2 activity and cyclin A promoter activity in vascular smooth muscle cells by p27(KIP1), an inhibitor of neointima formation in the rat carotid artery.Journal of Clinical Investigation, 1997
- Mechanism of action of the immunosuppressant rapamycinLife Sciences, 1995
- Role of the Ubiquitin-Proteasome Pathway in Regulating Abundance of the Cyclin-Dependent Kinase Inhibitor p27Science, 1995
- RAPAMYCIN, A POTENT IMMUNOSUPPRESSIVE DRUG, CAUSES PROGRAMMED CELL DEATH IN B LYMPHOMA CELLSTransplantation, 1995
- Inhibitors of mammalian G1 cyclin-dependent kinases.Genes & Development, 1995
- Regulation of chemotaxis by the platelet-derived growth factor receptor-βNature, 1994
- Molecular biology of intimal proliferationCurrent Opinion in Cardiology, 1993
- Negative Regulation of G1 in Mammalian Cells: Inhibition of Cyclin E-Dependent Kinase by TGF-βScience, 1993
- Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.The Journal of cell biology, 1992
- Modified Elastic Tissue-Masson Trichrome StainStain Technology, 1984